- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
- Specific Immunotherapy (SIT)
Allergy Immunotherapy Market size was valued at USD 2.2 billion in 2022 and is poised to grow at a CAGR of 9.2% from 2023 to 2029. Owing to the growing occurrence of sensitivities such as allergies and ineffective treatment procedures, such as pharmacotherapy, to control the prevalence rate of allergies are the major factors boosting the adoption of the allergy immunotherapy Market, which is considered as a designated treatment for various types of allergies. Increasing death rates due to allergies is the main reason why the government is supporting investing in research and development to provide better and improved treatment options for patients. Allergy immunotherapy is a treatment that prevents allergic reactions from a variety of sources, including food, grass pollen, dust, and bee venom. Allergy immunotherapy helps people with allergies such as rhinitis, asthma, and conjunctivitis, among other allergies, regulate their symptoms. Allergy immunotherapy is regular injections that gradually increase the dosage in order to create resistance in the patient. Because of the increased creation of blocking antibodies that combat the foreign chemicals that cause allergies, the patient's immunity system becomes less brittle when the dosage is gradually increased.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The prevalence of allergic patients are being increasing every year. According to the WAO (World Allergy Organization), a prominent growth in the ubiquity of allergies has been observed in the recent past. More than 30% of the total global population are suffering from allergic rhinitis. According to Health Statistics, around 8% of the U.S. adults suffer from sinusitis and hay fever. To create awareness among the population on allergies, number of government organizations came forward to support the program to create awareness among the population regarding the benefits of the allergy immunotherapy.
The allergy immunotherapy market size was valued at USD 2.2 billion in 2022 and is poised to grow at a CAGR of 9.2% from 2023 to 2029
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
1.Executive Summary |
2.Global Bispecific Antibody Market Introduction |
2.1.Global Bispecific Antibody Market - Taxonomy |
2.2.Global Bispecific Antibody Market - Definitions |
2.2.1.Treatment Type |
2.2.2.Allergy Type |
2.2.3.Distribution Channel |
2.2.4.Region |
3.Global Bispecific Antibody Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Bispecific Antibody Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Bispecific Antibody Market By Treatment Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Subcutaneous Immunotherapy (SCIT) |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Sublingual Immunotherapy (SLIT) |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Specific Immunotherapy (SIT) |
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Bispecific Antibody Market By Allergy Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Allergic Rhinitis |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Asthma |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Food Allergy |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Venom Allergy |
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Others |
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.Global Bispecific Antibody Market By Distribution Channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. Hospital Pharmacy |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Retail Pharmacy and Drug Stores |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Online Pharmacy |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Bispecific Antibody Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Bispecific Antibody Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Subcutaneous Immunotherapy (SCIT) |
9.1.2.Sublingual Immunotherapy (SLIT) |
9.1.3.Specific Immunotherapy (SIT) |
9.2. Allergy Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Allergic Rhinitis |
9.2.2.Asthma |
9.2.3.Food Allergy |
9.2.4.Venom Allergy |
9.2.5.Others |
9.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospital Pharmacy |
9.3.2.Retail Pharmacy and Drug Stores |
9.3.3.Online Pharmacy |
9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Bispecific Antibody Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Treatment Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Subcutaneous Immunotherapy (SCIT) |
10.1.2.Sublingual Immunotherapy (SLIT) |
10.1.3.Specific Immunotherapy (SIT) |
10.2. Allergy Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Allergic Rhinitis |
10.2.2.Asthma |
10.2.3.Food Allergy |
10.2.4.Venom Allergy |
10.2.5.Others |
10.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospital Pharmacy |
10.3.2.Retail Pharmacy and Drug Stores |
10.3.3.Online Pharmacy |
10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) Bispecific Antibody Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Treatment Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Subcutaneous Immunotherapy (SCIT) |
11.1.2.Sublingual Immunotherapy (SLIT) |
11.1.3.Specific Immunotherapy (SIT) |
11.2. Allergy Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Allergic Rhinitis |
11.2.2.Asthma |
11.2.3.Food Allergy |
11.2.4.Venom Allergy |
11.2.5.Others |
11.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospital Pharmacy |
11.3.2.Retail Pharmacy and Drug Stores |
11.3.3.Online Pharmacy |
11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Bispecific Antibody Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Treatment Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Subcutaneous Immunotherapy (SCIT) |
12.1.2.Sublingual Immunotherapy (SLIT) |
12.1.3.Specific Immunotherapy (SIT) |
12.2. Allergy Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Allergic Rhinitis |
12.2.2.Asthma |
12.2.3.Food Allergy |
12.2.4.Venom Allergy |
12.2.5.Others |
12.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospital Pharmacy |
12.3.2.Retail Pharmacy and Drug Stores |
12.3.3.Online Pharmacy |
12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Bispecific Antibody Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
13.1. Treatment Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Subcutaneous Immunotherapy (SCIT) |
13.1.2.Sublingual Immunotherapy (SLIT) |
13.1.3.Specific Immunotherapy (SIT) |
13.2. Allergy Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Allergic Rhinitis |
13.2.2.Asthma |
13.2.3.Food Allergy |
13.2.4.Venom Allergy |
13.2.5.Others |
13.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospital Pharmacy |
13.3.2.Retail Pharmacy and Drug Stores |
13.3.3.Online Pharmacy |
13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Stallergenes Greer |
14.2.2.ALK |
14.2.3.Allergy Therapeutics |
14.2.4.Merck KGaA |
14.2.5.HAL Allergy B.V. |
14.2.6.Biomay AG |
14.2.7.Anergis |
14.2.8.Aimmune Therapeutics |
14.2.9.Circassia |
14.2.10.DBV Technologies |
15. Research Methodology |
16. Appendix and Abbreviations |